SCGB3A1 and rhabdomyosarcoma: Furthermore, high percentage of aberrant methylation of SCGB3A1 promoter in rhabdomyosarcoma patients indicates SCGB3A1 should be considered as a potential clinical target for assessment of the most common type of soft tissue sarcoma for children.